SOM General Information
SomnoMed Limited | |
SOM | |
http://www.somnomed.com.au | |
Health Care Equipment | |
102 | |
63 |
SOM Current Share Price+
Current Price | $1.630 |
Open | $1.630 |
High | $1.630 |
Low | $1.630 |
Last Close | $1.630 |
Volume | 3353 |
Price Movement | - ( No change ) |
- +Security prices are delayed by at least 20 minutes and are indicative only.
SOM Research
SOM Company Overview
Business Description
SOM Financial Summary
Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
---|---|---|---|---|---|---|---|
2018 A | -10.57 | -15.30 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
2017 A | -4.09 | -6.10 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
2016 A | -0.37 | -0.50 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
SOM Peer Comparison
Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
2016 A | 2017 A | 2018 A | 2016 A | 2017 A | 2018 A | 2016 A | 2017 A | 2018 A | ||
Cochlear (COH) | $10,307M | 0.0828 | 0.1221 | 0.1419 | 42.3858 | 37.7731 | 33.0796 | 1.68% | 1.81% | 2.07% |
Fisher & Paykel Hlth (FPH) | $7,371M | 0.1095 | 0.0397 | 0.1402 | 38.3125 | 36.8512 | 32.3189 | 1.55% | 1.83% | 2.14% |
ResMed (RMD) | $5,586M | 0.2815 | 0.0556 | 0.1410 | 32.2698 | 30.5699 | 26.7928 | 1.36% | 1.73% | 1.98% |
SomnoMed (SOM) | $102M | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
SOM Market Comparison
Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
---|---|---|---|---|
Company | 3.00 | 0.00 | 2.62 | 0.00 |
Market | 0.68 | 14.50 | 1.20 | 1.18 |
Sector | 0.82 | 17.90 | 1.81 | 2.73 |
SOM Directors
Name | Position | Start Date |
---|---|---|
Ms Lee Ausburn | Non-Executive Director | 30 Sep 2011 |
Mr Robert Scherini | Non-Executive Director | 30 Sep 2011 |
Mr Hamish Corlett | Non-Executive Director | 1 May 2018 |
Dr Peter Neustadt | Non-Executive Director, Non-Executive Chairman | 13 Nov 2006 |
SOM Management
Name | Position |
---|---|
Derek Smith | Chief Executive Officer |
Jim Evanger | Chief Executive Officer of Renew Sleep Solutions, Inc. |
Neil Verdal-Austin | Chief Financial Officer and Executive Vice President Asia Pacific |
Terence Anthony Flitcroft | Company Secretary |
Kien Nguyen | Executive President - North America |
Martin Weiland | Executive Vice President - Sales and Marketing Europe |
SOM Substantial Shareholders
Holding | Name |
---|---|
12,422,014 (19.97%) | TDM Asset Management Pty Ltd and its associates |
5,122,846 (8.23%) | Dottie Investments Pty Limited |
3,424,861 (5.51%) | National Nominees Ltd |
3,377,651 (5.43%) | FIL Limited and the entities |
SOM Calendar of Events
Date | Event |
---|---|
27 September 2019 | Report (Annual) |
18 September 2019 | Report (Annual) |
21 August 2019 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.